Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Borin ML et al. [Relation between the changes in Na+/H+-exchange and cytoplasmic Ca levels in platelet activation]. 1988 Biull Eksp Biol Med pmid:2844320
Joseph R et al. Cytosolic ionized calcium homeostasis in platelets: an abnormal sensitivity to PAF-activation in migraine. 1988 Headache pmid:2844693
Arnoux B et al. Effect of PAF-acether in non-human primates. 1988 Prog. Clin. Biol. Res. pmid:2837781
Livio M et al. Role of platelet-activating factor in primary hemostasis. 1988 Am. J. Physiol. pmid:2837916
Bekker AY et al. Dose-response relationships between platelet activating factor and permeability--surface area product of FITC-dextran 150 in the hamster cheek pouch. 1988 Microcirc Endothelium Lymphatics pmid:2475751
Vivier E et al. Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression. 1988 Eur. J. Immunol. pmid:2895712
Hoffman DR et al. Synthesis of platelet activating factor by cholinephosphotransferase in developing fetal rabbit lung. 1988 Lipids pmid:2897059
Leff AR Neurohumoral regulation of airway contractile responses. 1988 Chest pmid:2897271
Junier MP et al. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus. 1988 Endocrinology pmid:2898362
Bachelet M et al. Interaction between PAF-acether and drugs that stimulate cyclic AMP in guinea-pig alveolar macrophages. 1988 Eur. J. Pharmacol. pmid:2840303
Crouch MF and Lapetina EG No direct correlation between Ca2+ mobilization and dissociation of Gi during platelet phospholipase A2 activation. 1988 Biochem. Biophys. Res. Commun. pmid:3132162
Russell JA et al. Changes in the levels of bioactive components of cotton bracts accompanying senescence. 1988 Lung pmid:3132575
Martins MA et al. Intravenous injections of PAF-acether induce platelet aggregation in rats. 1988 Eur. J. Pharmacol. pmid:3135199
Peers SH Dexamethasone inhibits platelet activating factor-induced inflammation in the paw but not the pleural cavity of rats. 1988 Eur. J. Pharmacol. pmid:3136026
Mangold HK Synthesis of biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3136454
Anderson GP et al. Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. 1988 Agents Actions pmid:3136622
Levine L Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism. 1988 Mol. Pharmacol. pmid:2849046
Ferrell JE et al. Membrane bilayer balance and platelet shape: morphological and biochemical responses to amphipathic compounds. 1988 Biochim. Biophys. Acta pmid:3355815
López-Farré A et al. Glomeruli from ischemic rat kidneys produce increased amounts of platelet activating factor. 1988 Biochem. Biophys. Res. Commun. pmid:3358756
Kuiper J et al. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. 1988 Biochem. Biophys. Res. Commun. pmid:3144970
Valone FH and Epstein LB Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. 1988 J. Immunol. pmid:3141509
Berti F et al. New pharmacological data on the bronchospasmolytic activity of bamifylline. 1988 Arzneimittelforschung pmid:3365275
Sun XM and Hsueh W Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. 1988 J. Clin. Invest. pmid:3366898
Calignano A et al. Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin. 1988 J Pharmacol Methods pmid:3367652
Nolte D [Bronchial hyperreactivity: pingpong between cells, nerves and mediators]. 1988 Med. Klin. (Munich) pmid:3367876
Smith RJ et al. Diacylglycerols modulate human polymorphonuclear neutrophil responsiveness: effects on intracellular calcium mobilization, granule exocytosis, and superoxide anion production. 1988 J. Leukoc. Biol. pmid:2836539
Rydzewska G and Gabryelewicz A [Platelet activating factor (PAF) and its inhibitors]. 1988 Pol. Arch. Med. Wewn. pmid:2482481
Jouquey S et al. Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. 1988 Agents Actions pmid:2459935
Spinks NR and O'Neill C Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse embryos. 1988 J. Reprod. Fertil. pmid:2460623
Dorsch W et al. Anti-asthmatic effects of onions. Alk(en)ylsulfinothioic acid alk(en)yl-esters inhibit histamine release, leukotriene and thromboxane biosynthesis in vitro and counteract PAF and allergen-induced bronchial obstruction in vivo. 1988 Biochem. Pharmacol. pmid:2462422
Barnes PJ Inflammatory mechanisms and nocturnal asthma. 1988 Am. J. Med. pmid:3041827
Camussi G and Salvidio G Platelet-activating factor in graft rejection. 1988 Prog Biochem Pharmacol pmid:3043426
Hénocq E PAF-acether and eosinophils. 1988 Prog Biochem Pharmacol pmid:3043428
Lagente V and Fortes ZB Role of PAF-acether in the vascular events of inflammation. 1988 Prog Biochem Pharmacol pmid:3043429
Cordeiro RS et al. Proinflammatory activity of platelet-activating factor: pharmacological modulation and cellular involvement. 1988 Prog Biochem Pharmacol pmid:3043430
Pirotzky E and Braquet P PAF-acether and kidney pathology. 1988 Prog Biochem Pharmacol pmid:3043431
Feuerstein G and Siren AL Platelet-activating factor and shock. 1988 Prog Biochem Pharmacol pmid:3043432
There is a case for PAF-acether antagonists. Abstracts of the conference. Paris, France, May 25-27, 1988. 1988 Prostaglandins pmid:3399682
Valone FH Platelet-activating factor binding and metabolism during human platelet aggregation. 1988 Thromb. Res. pmid:3400077
Bratton DL et al. Effects of platelet activating factor on calcium-lipid interactions and lateral phase separations in phospholipid vesicles. 1988 Biochim. Biophys. Acta pmid:3401478
Evans TW et al. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man. 1988 Br. J. Pharmacol. pmid:3401633
Lagente V et al. Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig. 1988 Br. J. Pharmacol. pmid:3401641
Groscurth P et al. Effects of platelet activating factor (PAF) on human citrated whole blood. 1988 Eur. J. Haematol. pmid:3402585
Rylander R et al. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP). 1988 Int. Arch. Allergy Appl. Immunol. pmid:3403044
Tamura N et al. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. 1988 J. Immunol. pmid:2848892
Pretolani M et al. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. 1988 Am. Rev. Respir. Dis. pmid:3202509
Pirotzky E and Braquet P [The role of the platelet-activating factor (PAF-acether) in renal pathology]. 1988 Presse Med pmid:2966954
Willuweit B and Aktories K Heparin and heparinoids impair adrenaline and platelet-activating factor but not thrombin-induced inhibition of adenylate cyclase and stimulation of GTP hydrolysis in human platelet membranes. 1988 Naunyn Schmiedebergs Arch. Pharmacol. pmid:2969081
Jancar S et al. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. 1988 Prostaglandins pmid:2969600
Tkhostov EB et al. [Calcium metabolism in arterial hypertension. I. Myocardial hypertrophy and hormone-dependent increase in Ca2+ levels in the thrombocytes of patients with arterial hypertension]. 1988 Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR pmid:2969736
Wallace JL Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. 1988 Can. J. Physiol. Pharmacol. pmid:3167675
Stenson WF Platelet-activating factor and inflammatory bowel disease. 1988 Gastroenterology pmid:3169505
Valone FH et al. Enhanced human monocyte cytotoxicity by platelet-activating factor. 1988 Immunology pmid:3169845
Popovich KJ et al. Role of platelets in contraction of canine tracheal muscle elicited by PAF in vitro. 1988 J. Appl. Physiol. pmid:3170437
Moriyama T et al. Elevation of cytosolic free Ca2+ is directly evoked by thromboxane A2 in human platelets during activation with collagen. 1988 J. Biochem. pmid:3170519
Lagente V et al. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists. 1988 J. Pharmacol. Exp. Ther. pmid:3171975
Benveniste J et al. Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins. 1988 FEBS Lett. pmid:3338565
Lagente V et al. Involvement of PAF-acether in anaphylactic bronchoconstriction induced in guinea pigs by aerosolized antigen. 1988 Int. Arch. Allergy Appl. Immunol. pmid:3338855
Imai T et al. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021. 1988 J. Lab. Clin. Med. pmid:3339274
Wichrowski B et al. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres. 1988 J. Med. Chem. pmid:3339611
Tilley JW et al. Pyrido[2,1-b]quinazolinecarboxamide derivatives as platelet activating factor antagonists. 1988 J. Med. Chem. pmid:3339617
Ferguson MK et al. Lymphatic smooth muscle responses to leukotrienes, histamine and platelet activating factor. 1988 J. Surg. Res. pmid:3339877
Kelefiotis D et al. Study of digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorylcholine (AGEPC) in mice. 1988 Life Sci. pmid:3339951
Valone FH Identification of platelet-activating factor receptors in P388D1 murine macrophages. 1988 J. Immunol. pmid:2832476
Homma H and Hanahan DJ Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics. 1988 Arch. Biochem. Biophys. pmid:2833174
Huang SJ et al. Platelet-activating factor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate stimulates the production of reactive oxygen intermediates in macrophages. 1988 Biochem. J. pmid:2833227
Rees RS et al. Plasma components are required for platelet activation by the toxin of Loxosceles reclusa. 1988 Toxicon pmid:3245050
Brass LF et al. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. 1988 J. Biol. Chem. pmid:2833506
Blank ML et al. Stimulation of the de novo pathway for the biosynthesis of platelet-activating factor (PAF) via cytidylyltransferase activation in cells with minimal endogenous PAF production. 1988 J. Biol. Chem. pmid:2833508
Mencia-Huerta JM et al. [Effect of long-term administration of platelet activating factor on pulmonary response and morphology in the guinea pig]. 1988 Allerg Immunol (Paris) pmid:3245884
Rola-Pleszczynski M et al. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells. 1988 J. Immunol. pmid:2834440
Takeuchi N et al. The antagonist effects of compounds derived from khellactone on platelet-activating factor. 1988 Chem. Pharm. Bull. pmid:3245999
Worthen GS et al. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. 1988 J. Immunol. pmid:2834441
Hofmann B et al. Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator. 1988 Biomed. Biochim. Acta pmid:3248103
Mest HJ et al. The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids. 1988 Biomed. Biochim. Acta pmid:3248107
Wainwright CL et al. The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation. 1988 Biomed. Biochim. Acta pmid:3248108
Prpic V et al. Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages. 1988 J. Cell Biol. pmid:2839520
Kroegel C The potential pathophysiological role of platelet-activating factor in human diseases. 1988 Klin. Wochenschr. pmid:2839728
Leslie CC et al. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7. 1988 Biochim. Biophys. Acta pmid:3143418
Egger M et al. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release. 1988 Biochim. Biophys. Acta pmid:3143424
Hammerschmidt DE et al. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor. 1988 J. Lab. Clin. Med. pmid:2840477
Pitcock JA Morphometric studies of the renomedullary interstitial cells. 1988 Am. J. Med. Sci. pmid:3284348
Hwang SB et al. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor. 1988 J. Pharmacol. Exp. Ther. pmid:2841449
Parnham MJ PAF receptors. 1988 Prog Biochem Pharmacol pmid:2841664
Shkhvatsabaia IK et al. [Receptor-dependent regulation of the concentration of Ca2+ in the cytoplasm of thrombocytes in hypertensive patients]. 1988 Kardiologiia pmid:2842537
Tahraoui L et al. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. 1988 Mol. Pharmacol. pmid:2842653
Croft KD et al. The effect of dietary fish oil and long-term salt loading on blood pressure and eicosanoid metabolism in spontaneously hypertensive rats. 1988 Clin. Exp. Pharmacol. Physiol. pmid:3271614
Ng DS and Wong K Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets. 1988 Eur. J. Pharmacol. pmid:2846326
Avdonin PV et al. Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. 1988 Thromb. Res. pmid:3232128
Storch J et al. Influence of platelet activating factor and a nonmetabolizable analogue on superoxide production by bone marrow derived macrophages. 1988 J. Leukoc. Biol. pmid:2846728
Kiktev VG et al. [Calcium metabolism of the thrombocytes in ischemic heart disease]. 1988 Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR pmid:3233156
Bussolino F et al. Acetylcholine and dopamine promote the production of platelet activating factor in immature cells of chick embryonic retina. 1988 J. Neurochem. pmid:2846783
Yamada K et al. Highly sensitive gas chromatographic--mass spectrometric method for the determination of platelet-activating factor in human blood. 1988 J. Chromatogr. pmid:3235552
Birkle DL et al. Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. 1988 J. Neurochem. pmid:2846788
Yoshikawa D and Goto F [Interactions between platelet activating factor and leukotrienes during endotoxin shock in the rat]. 1988 Masui pmid:3236398
Wykle RL et al. Platelet-activating factor. 1988 Meth. Enzymol. pmid:3237085
Rouis M et al. Platelet activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophages. 1988 Biochem. Biophys. Res. Commun. pmid:2847729
Kioumis I et al. Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man. 1988 Prostaglandins pmid:3237997
Doni MG et al. Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses. 1988 Biochem. Biophys. Res. Commun. pmid:2847730
Fradin A et al. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'. 1988 Biochim. Biophys. Acta pmid:2848583